about
PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.Glial and neuroinflammatory targets for treating substance use disorders.PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
PPARγ agonism attenuates cocaine cue reactivity.
@en
PPARγ agonism attenuates cocaine cue reactivity.
@nl
type
label
PPARγ agonism attenuates cocaine cue reactivity.
@en
PPARγ agonism attenuates cocaine cue reactivity.
@nl
prefLabel
PPARγ agonism attenuates cocaine cue reactivity.
@en
PPARγ agonism attenuates cocaine cue reactivity.
@nl
P2093
P2860
P356
P1433
P1476
PPARγ agonism attenuates cocaine cue reactivity.
@en
P2093
Kathryn A Cunningham
Kelly T Dineley
Larry Denner
Robert G Fox
Scott D Lane
Sonja J Stutz
William R Miller
P2860
P356
10.1111/ADB.12471
P577
2016-11-11T00:00:00Z